Jim Simons’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $820K | Sell |
82,100
-42,172
| -34% | -$320K | ﹤0.01% | 2404 |
|
|
2026
Q1 | $895K | Buy |
124,272
+71,472
| +135% | +$459K | ﹤0.01% | 2327 |
|
|
2025
Q4 | $298K | Sell |
52,800
-410,900
| -89% | -$2.23M | ﹤0.01% | 2765 |
|
|
2025
Q3 | $2.86M | Buy |
+463,700
| New | +$2.71M | ﹤0.01% | 1840 |
|
|
2025
Q2 | – | Sell |
-175,400
| Closed | -$649K | – | 3863 |
|
|
2025
Q1 | $649K | Buy |
175,400
+92,907
| +113% | +$398K | ﹤0.01% | 2628 |
|
|
2024
Q4 | $330K | Buy |
82,493
+9,281
| +13% | +$51K | ﹤0.01% | 3001 |
|
|
2024
Q3 | $510K | Sell |
73,212
-204,352
| -74% | -$1.66M | ﹤0.01% | 2784 |
|
|
2024
Q2 | $1.57M | Buy |
277,564
+208,793
| +304% | +$1.87M | ﹤0.01% | 2027 |
|
|
2024
Q1 | $916K | Buy |
68,771
+30,700
| +81% | +$287K | ﹤0.01% | 2540 |
|
|
2023
Q4 | $234K | Buy |
38,071
+9,501
| +33% | +$30.4K | ﹤0.01% | 3080 |
|
|
2023
Q3 | $72K | Buy |
28,570
+900
| +3% | +$3.49K | ﹤0.01% | 3313 |
|
|
2023
Q2 | $145K | Sell |
27,670
-11,093
| -29% | -$62.4K | ﹤0.01% | 3375 |
|
|
2023
Q1 | $184K | Sell |
38,763
-13,000
| -25% | -$78.1K | ﹤0.01% | 3304 |
|
|
2022
Q4 | $278K | Sell |
51,763
-15,722
| -23% | -$103K | ﹤0.01% | 3259 |
|
|
2022
Q3 | $472K | Sell |
67,485
-27,110
| -29% | -$273K | ﹤0.01% | 2956 |
|
|
2022
Q2 | $873K | Buy |
94,595
+10,023
| +12% | +$104K | ﹤0.01% | 2806 |
|
|
2022
Q1 | $1.52M | Buy |
84,572
+44,050
| +109% | +$777K | ﹤0.01% | 2431 |
|
|
2021
Q4 | $1.06M | Buy |
40,522
+13,732
| +51% | +$420K | ﹤0.01% | 2595 |
|
|
2021
Q3 | $960K | Buy |
26,790
+1,138
| +4% | +$48.3K | ﹤0.01% | 2574 |
|
|
2021
Q2 | $1.41M | Buy |
+25,652
| New | +$1.69M | ﹤0.01% | 2483 |
|
|
2021
Q1 | – | Sell |
-4,950
| Closed | -$563K | – | 3667 |
|
|
2020
Q4 | $563K | Sell |
4,950
-1,560
| -24% | -$98.7K | ﹤0.01% | 2767 |
|
|
2020
Q3 | $198K | Sell |
6,510
-2,190
| -25% | -$83.9K | ﹤0.01% | 3115 |
|
|
2020
Q2 | $382K | Buy |
8,700
+2,930
| +51% | +$122K | ﹤0.01% | 2956 |
|
|
2020
Q1 | $207K | Buy |
5,770
+1,901
| +49% | +$94.1K | ﹤0.01% | 3096 |
|
|
2019
Q4 | $258K | Buy |
3,869
+1,716
| +80% | +$189K | ﹤0.01% | 3105 |
|
|
2019
Q3 | $334K | Sell |
2,153
-7,867
| -79% | -$890K | ﹤0.01% | 3005 |
|
|
2019
Q2 | $864K | Buy |
10,020
+3,593
| +56% | +$392K | ﹤0.01% | 2750 |
|
|
2019
Q1 | $887K | Buy |
+6,427
| New | +$1.61M | ﹤0.01% | 2722 |
|
Other funds holding SLDB
SL
Jim Simons's SLDB Position: Q2 2026 in Review
Jim Simons reduced its Solid Biosciences (SLDB) stake by 34% in Q2 2026, selling an estimated $320K and leaving 82,100 shares worth $820K. The position accounts for ﹤0.01% of the portfolio, ranked #2404.
Jim Simons first reported a position in SLDB in Q1 2019 and has held it in 28 quarters since. The position peaked at $2.86M in Q3 2025. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.
- Jim Simons held 82,100 shares of Solid Biosciences worth $820K as of Q2 2026.
- Jim Simons sold 42,172 Solid Biosciences shares in Q2 2026, an estimated $320K.
- Solid Biosciences made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2404 holding.
- Jim Simons first reported a position in Solid Biosciences in Q1 2019 and has held it in 28 quarters since.
- Jim Simons's Solid Biosciences position peaked at $2.86M in Q3 2025.
- 156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.